Results 31 to 40 of about 273,871 (338)
Lung Adenocarcinoma in a Patient with Plasmacytoma [PDF]
Case Reports in Hematology, 2013 An increased risk of second malignancy is well recognized in patients treated for plasma cell neoplasms. However, second solid tumor is very rare in such patients. We report a case of a 68-year-old woman with plasmacytoma who developed lung adenocarcinoma.
Kazunori Nakase +7 more
openaire +4 more sources
Regulation of Ferroptosis in Lung Adenocarcinoma
International Journal of Molecular Sciences, 2023 Lung adenocarcinoma (LUAD) is the most common lung cancers, which accounts for about 35%-40% of all lung cancer patients. Despite therapeutic advancements in recent years, the overall survival time of the LUAD patients still remain poor, especially KRAS mutant LUAD.
Wei, Xiangyun +4 more
openaire +2 more sources
Improving diagnosis and prognosis of lung cancer using vision transformers: A scoping review [PDF]
arXiv, 2023 Vision transformer-based methods are advancing the field of medical artificial intelligence and cancer imaging, including lung cancer applications. Recently, many researchers have developed vision transformer-based AI methods for lung cancer diagnosis and prognosis.
arxiv
Lung adenocarcinoma promotion by air pollutants
Nature, 2023 A complete understanding of how exposure to environmental substances promotes cancer formation is lacking. More than 70 years ago, tumorigenesis was proposed to occur in a two-step process: an initiating step that induces mutations in healthy cells, followed by a promoter step that triggers cancer development1.
William Hill +211 more
openaire +7 more sources
Translational Oncology, 2022 Objectives: ARNTL2, as a circadian transcription factor, has been recently proposed to play an important role in a variety of tumors. however, the role of ARNTL2 in lung carcinogenesis and progression remains unclear.
Huan Zhang +10 more
doaj
Frontiers in Pharmacology, 2022 Tumor microenvironment plays an important role in the development, progression, and prognosis of lung adenocarcinoma. Exploring new biomarkers based on the immune microenvironment of lung adenocarcinoma can effectively predict the prognosis and provide ...
Xin Wang +8 more
doaj +1 more source
Invasive mucinous adenocarcinoma of the lung [PDF]
Translational Cancer Research, 2019 Invasive mucinous adenocarcinoma (IMA) is a unique histological subtype of adenocarcinoma. Due to its low incidence rates, survival data for IMA is scarce and often contradictory. The clinical manifestations of IMA are not precise as compared to other adenocarcinomas, with some patients having bronchial mucus overflow. Difference in immunohistochemical
Chenghui Li, Hongyang Lu, Lu Xu
openaire +3 more sources
Adaptive Fusion of Radiomics and Deep Features for Lung Adenocarcinoma Subtype Recognition [PDF]
arXiv, 2023 The most common type of lung cancer, lung adenocarcinoma (LUAD), has been increasingly detected since the advent of low-dose computed tomography screening technology. In clinical practice, pre-invasive LUAD (Pre-IAs) should only require regular follow-up care, while invasive LUAD (IAs) should receive immediate treatment with appropriate lung cancer ...
arxiv
TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma.
PLoS Genetics, 2020 Lung cancer is the leading cause of cancer-related death and lung adenocarcinoma is its most common subtype. Although genetic alterations have been identified as drivers in subsets of lung adenocarcinoma, they do not fully explain tumor development ...
Daniel J Mullen +8 more
doaj +1 more source
Scientific Reports, 2021 Genetic alterations underlying the development of lung cancer in individuals with idiopathic pulmonary fibrosis (IPF) have remained unclear. To explore whether genetic alterations in IPF tissue contribute to the development of IPF-associated lung cancer,
Yasuto Yoneshima +11 more
doaj +1 more source